Selected article for: "acute sars cov respiratory syndrome coronavirus and adipose tissue"
Author: Engin, Ayse Basak; Engin, Evren Doruk; Engin, Atilla
Title: Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
  • Cord-id: 60rzbotx
  • Document date: 2020_5_15
    • ID: 60rzbotx
    Snippet: The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air polluti
    Document: The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air pollution and SARS-CoV-2 infection, as more severe COVID-19 symptoms occur in smokers; comorbid conditions due to obesity or excess ectopic fat accumulation as underlying risk factors for severe COVID-19 strongly encourage the virus/ACE2 receptor-ligand interaction concept. Indeed, obesity, air pollution and smoking associated risk factors share underlying pathophysiologies that are related to the Renin-Angiotensin-System in SARS-CoV-2 infection. The aim of this review is to emphasize the mechanism of receptor-ligand interaction and its impact on the enhanced risk of death due to SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and local tissue: 1, 2, 3
    • acute ards respiratory distress syndrome and low albumin: 1, 2, 3
    • acute ards respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and low mortality rate: 1, 2, 3, 4
    • adaptive immune response and adipose tissue: 1, 2, 3
    • adaptive immune response and lung damage: 1, 2, 3, 4, 5, 6
    • adaptive immune response and lung disease: 1, 2, 3, 4, 5, 6
    • adaptive immune response and lung epithelial cell: 1
    • adaptive immune response and lung function: 1, 2, 3, 4
    • adaptive immune response and lung inflammation: 1, 2, 3, 4
    • adaptive immune response and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • low mortality and lung damage: 1, 2, 3, 4
    • low mortality and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • low mortality and lung epithelial cell: 1
    • low mortality and lung function: 1, 2, 3, 4, 5, 6
    • low mortality and lung inflammation: 1, 2, 3, 4
    • low mortality and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lung damage and lymphocyte subset: 1